Verdict at a Glance Bioglutide (NA-931) presents a novel quadruple-agonist mechanism that is scientifically ambitious, targeting GLP-1, GIP, glucagon, and IGF-1 receptors in a single oral molecule
La preocupacin radica en que muchos usuarios utilizan estos frmacos sin una supervisin mdica que incluya el monitoreo de la salud de sus huesos
A., Butler, J., Rasmussen, S., Davies, M., Hovingh, G
Rosenstock J., Ferrannini E
The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins